Tag: #Global Trends

Following the FDA's approval of Auvelity for treating agitation associated with Alzheimer's disease (ADA), Axsome Therapeutics has significantly increased its... Read more

Pharmaceutical giant Novartis has announced plans to build a new manufacturing facility in Morrisville, North Carolina. This marks the seventh... Read more

Biopharmaceutical giant Amgen has announced an additional $300 million investment in its manufacturing site in Juncos, Puerto Rico. This latest... Read more

The National Health Service (NHS) in England has officially begun offering a subcutaneous injection for cancer immunotherapy. This breakthrough reduces... Read more

The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of tens of thousands of infant formula cans... Read more

Pharmaceutical giant Bayer has initiated a voluntary recall of over 786,000 units of Afrin Original nasal spray in the U.S.... Read more

The FDA has officially approved Veppanu (vepdegestrant; ARV-471), a first-in-class oral selective estrogen receptor degrader (SERD) using PROTAC technology. Developed... Read more

Ray Therapeutics has reached a pivotal regulatory milestone as its lead candidate, RTx-015, was granted Priority Medicines (PRIME) designation by... Read more

Bristol Myers Squibb (BMS) is generating investor buzz with its late-stage pipeline despite a modest Q1 2026 financial performance. The... Read more